These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38178276)

  • 21. Rhamnolipid-Coated Iron Oxide Nanoparticles as a Novel Multitarget Candidate against Major Foodborne E. coli Serotypes and Methicillin-Resistant S. aureus.
    Sharaf M; Sewid AH; Hamouda HI; Elharrif MG; El-Demerdash AS; Alharthi A; Hashim N; Hamad AA; Selim S; Alkhalifah DHM; Hozzein WN; Abdalla M; Saber T
    Microbiol Spectr; 2022 Aug; 10(4):e0025022. PubMed ID: 35852338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The challenge of treating biofilm-associated bacterial infections.
    del Pozo JL; Patel R
    Clin Pharmacol Ther; 2007 Aug; 82(2):204-9. PubMed ID: 17538551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymol-Decorated Gold Nanoparticles for Curing Clinical Infections Caused by Bacteria Resistant to Last-Resort Antibiotics.
    Huang Z; Zhang X; Yao Z; Han Y; Ye J; Zhang Y; Chen L; Shen M; Zhou T
    mSphere; 2023 Jun; 8(3):e0054922. PubMed ID: 37017551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzymatic dispersion of biofilms: An emerging biocatalytic avenue to combat biofilm-mediated microbial infections.
    Ramakrishnan R; Singh AK; Singh S; Chakravortty D; Das D
    J Biol Chem; 2022 Sep; 298(9):102352. PubMed ID: 35940306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanotechnologies for control of pathogenic microbial biofilms.
    Asare EO; Mun EA; Marsili E; Paunov VN
    J Mater Chem B; 2022 Jul; 10(27):5129-5153. PubMed ID: 35735175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promising Therapeutic Strategies Against Microbial Biofilm Challenges.
    Zhang K; Li X; Yu C; Wang Y
    Front Cell Infect Microbiol; 2020; 10():359. PubMed ID: 32850471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential application of antimicrobial peptides in the treatment of bacterial biofilm infections.
    Strempel N; Strehmel J; Overhage J
    Curr Pharm Des; 2015; 21(1):67-84. PubMed ID: 25189860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance.
    Natan M; Banin E
    FEMS Microbiol Rev; 2017 May; 41(3):302-322. PubMed ID: 28419240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eradicating biofilm infections: an update on current and prospective approaches.
    da Silva RAG; Afonina I; Kline KA
    Curr Opin Microbiol; 2021 Oct; 63():117-125. PubMed ID: 34333239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Strategies against Biofilm Infections.
    Mishra S; Gupta A; Upadhye V; Singh SC; Sinha RP; Häder DP
    Life (Basel); 2023 Jan; 13(1):. PubMed ID: 36676121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanomedicine against biofilm infections: A roadmap of challenges and limitations.
    Blanco-Cabra N; Alcàcer-Almansa J; Admella J; Arévalo-Jaimes BV; Torrents E
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(1):e1944. PubMed ID: 38403876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergism between metallic nanoparticles and antibiotics.
    Agreles MAA; Cavalcanti IDL; Cavalcanti IMF
    Appl Microbiol Biotechnol; 2022 Jun; 106(11):3973-3984. PubMed ID: 35670851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolving biofilm inhibition and eradication in clinical settings through plant-based antibiofilm agents.
    Silva E; Teixeira JA; Pereira MO; Rocha CMR; Sousa AM
    Phytomedicine; 2023 Oct; 119():154973. PubMed ID: 37499434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advancing antimicrobial strategies for managing oral biofilm infections.
    Jiao Y; Tay FR; Niu LN; Chen JH
    Int J Oral Sci; 2019 Oct; 11(3):28. PubMed ID: 31570700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic treatment of biofilm infections.
    Ciofu O; Rojo-Molinero E; Macià MD; Oliver A
    APMIS; 2017 Apr; 125(4):304-319. PubMed ID: 28407419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanotechnology-Based Drug Delivery Systems to Control Bacterial-Biofilm-Associated Lung Infections.
    Guo Y; Mao Z; Ran F; Sun J; Zhang J; Chai G; Wang J
    Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticle-Based Therapies for Wound Biofilm Infection: Opportunities and Challenges.
    Kim MH
    IEEE Trans Nanobioscience; 2016 Apr; 15(3):294-304. PubMed ID: 26955044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hybrid silver-gold nanoparticles suppress drug resistant polymicrobial biofilm formation and intracellular infection.
    Bhatia E; Banerjee R
    J Mater Chem B; 2020 Jun; 8(22):4890-4898. PubMed ID: 32285904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combatting antibiotic-resistant bacteria using nanomaterials.
    Gupta A; Mumtaz S; Li CH; Hussain I; Rotello VM
    Chem Soc Rev; 2019 Jan; 48(2):415-427. PubMed ID: 30462112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current progress and prospects of organic nanoparticles against bacterial biofilm.
    Li X; Chen D; Xie S
    Adv Colloid Interface Sci; 2021 Aug; 294():102475. PubMed ID: 34280601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.